Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets
Multiple studies suggested using different miRNAs as biomarkers for prognosis of
hepatocellular carcinoma (HCC). We aimed to assemble a miRNA expression database …
hepatocellular carcinoma (HCC). We aimed to assemble a miRNA expression database …
Theranostic fluorescent probes
The ability to gain spatiotemporal information, and in some cases achieve spatiotemporal
control, in the context of drug delivery makes theranostic fluorescent probes an attractive …
control, in the context of drug delivery makes theranostic fluorescent probes an attractive …
Metabolism‐associated molecular classification of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a disease with unique management complexity because
it displays high heterogeneity of molecular phenotypes. We herein aimed to characterize the …
it displays high heterogeneity of molecular phenotypes. We herein aimed to characterize the …
The protein histidine phosphatase LHPP is a tumour suppressor
Histidine phosphorylation, the so-called hidden phosphoproteome, is a poorly characterized
post-translational modification of proteins,. Here we describe a role of histidine …
post-translational modification of proteins,. Here we describe a role of histidine …
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages
CKY Ng, E Dazert, T Boldanova, M Coto-Llerena… - Nature …, 2022 - nature.com
Proteogenomic analyses of hepatocellular carcinomas (HCC) have focused on early-stage,
HBV-associated HCCs. Here we present an integrated proteogenomic analysis of HCCs …
HBV-associated HCCs. Here we present an integrated proteogenomic analysis of HCCs …
A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis
N Fujiwara, M Kobayashi, AJ Fobar, A Hoshida… - Med, 2021 - cell.com
Background Accurate non-invasive prediction of long-term hepatocellular carcinoma (HCC)
risk in advanced liver fibrosis is urgently needed for cost-effective HCC screening; however …
risk in advanced liver fibrosis is urgently needed for cost-effective HCC screening; however …
Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies
Background & Aims Microvascular invasion (MVI), a major risk factor for tumor recurrence
after surgery in hepatocellular carcinoma (HCC), is only detectable by microscopic …
after surgery in hepatocellular carcinoma (HCC), is only detectable by microscopic …
Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals
W Dai, Y Wang, T Yang, J Wang, W Wu… - Cell communication and …, 2019 - Springer
Abstract Background C-Type Lectin Domain Family 3 Member B (CLEC3B), is down-
regulated in serum and tumor tissues in different cancers including hepatocellular …
regulated in serum and tumor tissues in different cancers including hepatocellular …
[HTML][HTML] DNA topoisomerase 1 and 2A function as oncogenes in liver cancer and may be direct targets of nitidine chloride
LM Liu, DD **ong, P Lin, H Yang… - International …, 2018 - spandidos-publications.com
The aim of the present study was to determine the role of topoisomerase 1 (TOP1) and
topoisomerase 2A (TOP2A) in liver cancer (LC), and to investigate the inhibitory effect of …
topoisomerase 2A (TOP2A) in liver cancer (LC), and to investigate the inhibitory effect of …
A comprehensive genome‐wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma
H Cui, Y Zhang, Q Zhang, W Chen, H Zhao… - Cancer …, 2017 - Wiley Online Library
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide,
especially in East Asia and China. Long noncoding RNA s (lnc RNA s) are emerging as …
especially in East Asia and China. Long noncoding RNA s (lnc RNA s) are emerging as …